Alnylam Pharmaceuticals
ALNY
#799
Rank
A$44.09 B
Marketcap
A$329.57
Share price
2.47%
Change (1 day)
-54.40%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company